Clinical analysis of 21 patients with psoriasis arthropathy

Journal of Dermatology

Volumn 32, Issue 2, 2005, Pages 84-90

  Yamamoto, Toshiyuki ^a   Yokozeki, Hiroo ^a   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Joint; Psoriasis arthropathy; Skin

Indexed keywords

ANTINUCLEAR ANTIBODY; BUCILLAMINE; CD45RO ANTIGEN; CYCLOSPORIN; ETRETINATE; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; METHOTREXATE; MIZORIBINE; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INFLAMMATORY CELL; JOINT BIOPSY; MALE; PSORIATIC ARTHRITIS; SPONDYLOARTHROPATHY;

EID: 15744378791     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00722.x     Document Type: Article

References (27)

1. Gladman DD: Current concepts in psoriatic arthritis, Curr Opin Rheumatol, 14: 361-366, 2002.
2. Costello P, FitzGerald O: Disease mechanisms in psoriasis and psoriatic arthritis, Curr Rheumatol Rep, 3: 419-427, 2001.
3. Veale DJ, FitzGerald O: Psoriatic arthritis: Pathogenesis and epidemiology, Clin Exp Rheumatol, 20: s27-s33, 2002.
4. Espinoza LR, Cuellar ML, Silveira LH: Psoriasis arthritis, Curr Opin Rheumatol, 4: 470-480, 1992.
5. Scarpa R, Oriente P, Pucino A, et al: Psoriatic arthritis in psoriatic patients, Br J Rheumatol, 23: 246-250, 1984.
6. Moll JMH, Wright V: Psoriatic arthritis, Semin Arthritis Rheum, 3: 55-78, 1973.
7. Fredriksson T, Pettersson U: Severe psoriasis: Oral therapy with a new retinoid, Dermatologica, 157: 238-244, 1978.
8. Kammer GM, Soter NA, Gibson DJ, Schur PH: Psoriatic arthritis: A clinical, immunologic and HLA study of 100 patients, Semin Arthritis Rheum, 9: 75-97, 1979.
9. Leonard DG, O'Duffy JD, Rogers RS: Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis, Mayo Clin Proc, 53: 511-518, 1978.
10. Torre AJC, Rodriguez PA, Arribas Castrillo JM, Ballina Garcia J, Riestra NJL, Lopez LC: Psoriasis arthritis (PA): A clinical, immunological and radiological study of 180 patients, Br J Rheumatol, 30: 245-250, 1991.
11. Veale D, Rogers S, Fitzgerald O: Classification of clinical subsets in psoriatic arthritis, Br J Rheumatol, 33: 133-138, 1994.
12. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ: Psoriatic arthritis: Outcome of disease subsets and relationship of joint disease to nail and skin disease, Br J Rheumatol, 33: 834-839, 1994.
13. Scarpa R, Manguso F, Oriente A, Peluso R, Atteno M, Oriente P: Is the involvement of the distal interphalangeal joint in psoriatic patients related to nail psoriasis? Clin Rheumatol, 23: 27-30, 2004.
14. Little M, Harvie JN, Lester RC: Psoriatic arthritis in severe psoriasis, Can Med Assoc J, 112: 317-319, 1975.
15. Elkayam O, Ophir J, Yaron M, Caspi D: Psoriatic arthritis: Interrelationships between skin and joint manifestations related to onset, course and distribution, Clin Rheumatol, 19: 301-305, 2000.
16. Gladman DD, Shuckett R, Russel ML, Thorne JC, Schachter RK: Psoriatic arthritis - An analysis of 220 patients, Q J Med, 62: 127-141, 1987.
17. Höhler T, Märker-Hermann E: Psoriatic arthritis: Clinical aspects, genetics, and the role of T cells, Curr Opin Rheumatol, 13: 273-279, 2001.
18. Jones SM, Dixey J, Hall ND, MuHugh NJ: Expression of the cutaneous lymphocyte antigen and its counter-receptor E-selectin in the skin and joints of patients with psoriatic arthritis, Br J Rheumatol, 36: 748-757, 1997.
19. Pitzalis C, Cauli A, Pipitone N, et al: Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis, Arthritis Rheum, 39: 137-145, 1996.
20. Terajima S, Higaki M, Igarashi Y, Nogita T, Kawashima M: An important role of tumor necrosis factor-α in the induction of adhesion molecules in psoriasis, Arch Dermatol Res, 290: 246-252, 1998.
21. Saklatvala J: Tumor necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage, Nature, 322: 547-549, 1986.
22. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors, Nature, 319: 516-518, 1986.
23. Shinmei M, Masuda K, Kikuchi T, Shimomura Y: The role of cytokines in chondrocyte mediated cartilage degradation, J Rheumatol, 6 (suppl 18): 32-34, 1989.
24. Bayer JM, Beutler B, Cerami A: Cachectin/Tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts, J Exp Med, 162: 2163-2168, 1985.
25. Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ: Patterns of cytokine production in psoriatic synovium, J Rheumatol, 25: 1544-1552, 1998.
26. Pipitone N, Kingsley GH, Manzo A, Scott DL, Pitzalis C: Current concepts and new developments in the treatment of psoriatic arthritis, Rheumatology, 42: 1138-1148, 2003.
27. Krueger G, Callis K: Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis, Arch Dermatol, 140: 218-225, 2004.